Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001047469-14-007857
Filing Date
2014-09-24
Accepted
2014-09-24 16:54:24
Documents
2

Document Format Files

Seq Description Document Type Size
1 424B3 a2221553z424b3.htm 424B3 135548
2 G906823.JPG g906823.jpg GRAPHIC 15528
  Complete submission text file 0001047469-14-007857.txt   158082
Mailing Address 9363 TOWNE CENTRE DRIVE SUITE 200 SAN DIEGO CA 92121
Business Address 9363 TOWNE CENTRE DRIVE SUITE 200 SAN DIEGO CA 92121 (514) 337-3333
Mirati Therapeutics, Inc. (Filer) CIK: 0001576263 (see all company filings)

EIN.: 462693615 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-198678 | Film No.: 141118793
SIC: 2834 Pharmaceutical Preparations